Analysis of CGGA data showed that C5aR1 expression increased with increasing glioma grade and that C5aR1 overexpression was associated with poor prognosis in patients with glioma, as indicated by the low survival rate of patients with high C5aR1 expression (Fig. 1A–C). Here, C5AR1 is linked to central nervous system cancer.